CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.

Acta Bioethica is a pivotal open access journal published by the Universidad de Chile's Centro Interdisciplinario de Estudios Bioética, dedicated to the multidisciplinary exploration of bioethical issues in health policy and social sciences. Since its inception in 2000, the journal has fostered dialogue among researchers, professionals, and students, addressing the complexities of ethical practices in diverse health contexts. With an impressive commitment to accessibility, Acta Bioethica has become a vital resource for those engaged in understanding the ethics of healthcare in Latin America and beyond. Although currently ranked in the lower quartiles of Scopus in both health policy and social sciences, the journal is steadily gaining recognition for its unique contributions to bioethics. The journal accepts contributions in both English and Spanish, ensuring a wider reach and impact in the academic community. Located in Santiago, Chile, and active from 2007 to 2024, Acta Bioethica continues to be an essential platform for advancing research and discussions in the ever-evolving field of bioethics.

THEORETICAL MEDICINE AND BIOETHICS, published by SPRINGER, is an esteemed journal dedicated to exploring the complex intersections of medicine, ethics, and law. With its ISSN 1386-7415 and E-ISSN 1573-1200, this journal serves as a vital platform for scholars, practitioners, and students interested in the ethical implications of medical practices and innovations. Although it currently holds a Q4 impact factor in the categories of Issues, Ethics and Legal Aspects and Medicine (Miscellaneous) as of 2023, its relevance is amplified by its commitment to fostering critical discourse in a rapidly evolving field. The journal features a diverse range of articles that address profound ethical dilemmas in healthcare, making it a significant resource for contemporary research from 1997 to the present. As an open-access journal, it ensures that cutting-edge knowledge is readily available, inviting contributions that challenge conventional thought and advance the field of bioethics.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Journal of Ethics is a premier academic journal devoted to the exploration and analysis of ethical theories and practices within various disciplines. Published by SPRINGER in the Netherlands, this prestigious journal has established itself within the field of Philosophy, boasting a commendable Q1 classification in the 2023 category quartiles. With an impressive Scopus rank of 145 out of 806 in the Arts and Humanities sector, it occupies the 82nd percentile, indicating its significant impact and reach. The journal aims to provide a platform for rigorous discussion and research that addresses contemporary ethical issues, making it an essential resource for researchers, professionals, and students alike. Although not an Open Access journal, it offers various access options to ensure that critical insights and scholarly contributions are disseminated widely.

Canadian Journal of Bioethics-Revue Canadienne de Bioethique, published by the Universite de Montreal, is a premier open-access journal dedicated to advancing the multidisciplinary field of bioethics since 2012. Emphasizing the complexities of ethical practices in health policy, it serves as a vital resource for researchers, professionals, and students engaged in health and philosophy. With its E-ISSN 2561-4665, the journal's content is freely accessible, fostering knowledge dissemination and academic collaboration. Although categorized in Q4 among Health Policy and Health (social science) in 2023, it holds a respectable Q2 status in Philosophy, reflecting its strong theoretical contributions. Covering a wide scope from 2018 to 2024, the journal encourages robust discourse on pressing ethical issues facing contemporary healthcare systems. For those seeking to connect with the evolving narratives in bioethics, this journal is indispensable.

NURSING ETHICS, published by SAGE PUBLICATIONS LTD, is a premier international journal dedicated to the exploration and examination of ethical issues within the field of nursing. Since its inception in 1994, the journal has consistently provided a critical platform for scholars and practitioners to discuss ethical dilemmas and address complex legal aspects affecting nursing practice. With a remarkable Q1 ranking in the categories of Issues, Ethics, and Legal Aspects, it ranks in the top percentile, boasting a 92nd percentile position among its peers. Although currently not an Open Access journal, NURSING ETHICS plays a crucial role in fostering dialogue and advancing knowledge in the rapidly evolving landscape of nursing ethics, making it an invaluable resource for researchers, professionals, and students alike. The journal's commitment to high-quality research ensures that vital ethical considerations remain at the forefront of nursing education and practice, reinforcing its significance in a field that is continually impacted by ethical challenges.

Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.